Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why Pfizer Partner BioNTech Shares Are Rising Today

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 6.31% at $142.50 after the company announced its Omicron-adapted COVID-19 vaccine candidates demonstrated high immune response against the Omicron variant.

Benzinga

CECO Environmental Acquires UK-Based Western Air Ducts For Undisclosed Sum

CECO Environmental Corp (NASDAQ:CECE) has completed the acquisition of Western Air Ducts (UK) Ltd. and its patented air control system Inteliair. Deal terms were not disclosed. Western Air Ducts is an industrial air quality consultancy and engineering firm. Both brands will be folded into CECO's industrial air platform immediately. This acquisition adds…

Benzinga

Coinbase Plunges After Downgrade, But Here's Why The Progression Higher Remains In Play

Coinbase Global Inc (NASDAQ: COIN) was trading almost 10% lower on Monday after receiving a downgrade from Goldman Sachs.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What 7 Analyst Ratings Have To Say About Blueprint Medicines

Within the last quarter, Blueprint Medicines (NASDAQ:BPMC) has observed the following analyst ratings:

Benzinga

Palo Alto Networks Whale Trades For June 27

A whale with a lot of money to spend has taken a noticeably bearish stance on Palo Alto Networks. Looking at options history for Palo Alto Networks (NASDAQ:PANW) we detected 16 strange trades.

Benzinga

This Is What Whales Are Betting On Atlassian Corporation

A whale with a lot of money to spend has taken a noticeably bearish stance on Atlassian Corporation. Looking at options history for Atlassian Corporation (NASDAQ:TEAM) we detected 17 strange trades.

Benzinga

Where Alnylam Pharmaceuticals Stands With Analysts

Analysts have provided the following ratings for Alnylam Pharmaceuticals (NASDAQ:ALNY) within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,600 Today

Cadence Design Sys (NASDAQ:CDNS) has outperformed the market over the past 5 years by 25.91% on an annualized basis producing an average annual return of 35.93%. Currently, Cadence Design Sys has a market capitalization of $42.85 billion.

Benzinga

Looking At Micron Technology's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Micron Technology (NASDAQ:MU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Luminar Technologies Joins Russell 2000 Index

Luminar Technologies Inc (NASDAQ:LAZR) has officially joined the U.S. Russell 2000 Index, effective June 27, 2022. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. About 30 million shares of Luminar's stock are expected to be purchased and held by…

Benzinga

EV Charging As Easy As Topping Off Tank With Gas: What's EVgo & GM's New Feature Is All About?

EVgo Inc (NASDAQ:EVGO) and General Motors Co (NYSE:GM) have made available Plug and Charge for all GM electric vehicles with DC fast-charging capability on the EVgo network. The feature enables EVgo GM customers to start a fast-charging session without opening a mobile app or swiping an RFID or credit card. The service utilizes the latest…

Benzinga

Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) presented multiple resmetirom abstracts at the European Association for the Study of the Liver's International Liver Congress. The data included new details on changes in FibroScan controlled attenuation parameter and liver stiffness measurement along with magnetic resonance elastography, which serves as critical non-invasive measures of liver stiffness and fibrosis. …

Benzinga

Nasdaq Drops 75 Points; Acutus Medical Shares Spike Higher

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 75 points on Monday.

Benzinga

Stocks That Hit 52-Week Lows On Monday

During Monday's session, 77 companies made new 52-week lows.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.

Benzinga

Short Volatility Alert: Airgain, Inc.

On Friday, shares of Legend Airgain, Inc. (NASDAQ: AIRG) experienced volatile short activity. After the activity, the stock price went up +6.29% to $9.12. The overall sentiment for AIRG has been Bearish.

Benzinga

What 10 Analyst Ratings Have To Say About Signature Bank

Analysts have provided the following ratings for Signature Bank (NASDAQ:SBNY) within the last quarter:

Benzinga

Where Atlassian Corporation Stands With Analysts

Over the past 3 months, 8 analysts have published their opinion on Atlassian Corporation (NASDAQ:TEAM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What To Know About B. Riley Securities's Downgrade of Bed Bath & Beyond

B. Riley Securities downgraded its rating of Bed Bath & Beyond (NASDAQ:BBBY) to Neutral with a price target of $7.00, changing its price target from $17.00 to $7.00. Shares of Bed Bath & Beyond are trading down 3.64% over the last 24 hours, at $6.75 per share.

Benzinga

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.63% on an annualized basis producing an average annual return of 10.11%. Currently, Biogen has a market capitalization of $31.20 billion.

Benzinga

Goldman Sachs Upgrades Robinhood Markets: Here's What You Need To Know

Goldman Sachs upgraded its rating of Robinhood Markets (NASDAQ:HOOD) to Neutral with a price target of $9.50, changing its price target from $11.50 to $9.50. Shares of Robinhood Markets are trading up 4.19% over the last 24 hours, at $8.34 per share.

Benzinga

BMO Capital Maintains Outperform Rating for Micron Technology: Here's What You Need To Know

BMO Capital has decided to maintain its Outperform rating of Micron Technology (NASDAQ:MU) and lower its price target from $115.00 to $85.00. Shares of Micron Technology are trading up 2.62% over the last 24 hours, at $59.97 per share.

Benzinga

Primoris Expands Utility Business With Acquisition Of PLH Group

Primoris Services Corp (NASDAQ:PRIM) has agreed to acquire PLH Group, Inc. for $470 million in cash. PLH Group is a utility-focused specialty construction company with a concentration in key fast-growing regions of the U.S. This transaction doubles the Power Delivery business and increases PRIM's Utilities segment to over 50% of pro forma revenue.…

Benzinga

Check Out What Whales Are Doing With WBD

A whale with a lot of money to spend has taken a noticeably bullish stance on Warner Bros.Discovery. Looking at options history for Warner Bros.Discovery (NASDAQ:WBD) we detected 17 strange trades.

Benzinga

Why This Analyst Says It's 'Simply A Good Time To Buy' Simply Good Foods

The recent pullback in Simply Good Foods Co.’s (NASDAQ: SMPL) shares offers “an attractive entry point” into a company offering stable growth in a volatile market, according to Stephens.

1 … 377 378 379 380

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

374,944 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.